Comparison of paclitaxel and docetaxel in dual HER2 blockade: efficacy and safety in neoadjuvant treatment of HER2-positive breast cancer. - Turkoglu E; Akdag Topal G; Yildirim S; Kinikoglu O; Sariyar Busery N; Aydogan M; Yildiz HS; Orman S; Bayramgil A; Gunes TK; Tunc MA; Majidova N; et al. (Breast cancer research and treatment, 2025)